Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | CREX | Common Stock | 2.02K | Mar 30, 2023 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | CREX | Stock Option (Right to buy) | 80K | Mar 30, 2023 | Common Stock | 53.3K | $7.59 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Issuer effectuated a 1:3 Reverse Stock Split on 03/27/2023. Amounts reflected in Table I and Table II of this Form 4 reflect post-split amounts. |
F2 | On June 1, 2020, the reporting person was granted an option to purchase 240,000 shares of common stock, which equals 80,000 shares of common stock post-split. The option vests in three equal annual installments based on certain performance criteria for each of the fiscal years ending December 31, 2020, 2021, and 2022. The performance criteria for 2022 have been met, as reported in Column 7 and included in Column 9 with previously vested and reported shares of grant. |